Write a Comment
20 Comments
A cure is not in the financial interest of pharma and their stakeholders. Do not expect a cure from any research funded by the US government. Our only hope is India or China.
I am HIV positive...I would be very happy to be the first South African agree for volunteer for a New stem transplant. Please I am so desparate.
I'm in the early stages of completing my Microbiology degree. I switched majors because I watched a video of a fifteen year old kid who was born with HIV. If I had only one cure, I'd give it to him. We all need reinsurance and hope for a cure. If it's not found before I graduate. It's the first thing I plan to be researching in.
I still reckon we could have A cure if not THE cure by AIDS 2014. I read a story last week (can't find the link) that mentioned a case from the early 90's of a HIV+ man who got a BMT. He died a year later but in his autopsy there was no sign of HIV There are Cord blood tests going on in europe and US if they work as I said before there is a cure. We will know soon They also seem confident of setting a preventative vaccine in the next 10 years new tests are planed for S.A and Thialand
I just want to be cured n have my life back! If this works...... It would mean getting my LIFE back!
MineMan, shooting the messengers is pointless. No new zinc finger nuclease (ZFN) clinical research, either from Sangamo or other groups, was presented at AIDS 2012. As for the two clinical trials you reference, I made a point of mentioning these (with hyperlinks) in my July 20 summary of the Towards an HIV Cure symposia.
I find it very strange that none of those covering the IAS meeting in DC mention the research and clinical trials that Sangamo Biosciences is doing. 2 PH II trials that were at CROI touted as a "functional cure", Several presentations by scientists and persons participating in the trials were passed over as non-events. When they may have been the most important of the meeting. Very dissapointed in the coverage.
Benny
truly amazing
February 14, 2013 • Beacon